Uncover key drivers, emerging technologies, and competitive movements shaping the mental health clinical trials market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Mental Health Clinical Trials Market?

The mental health clinical trials market has experienced substantial expansion over recent years. Forecasts show it is set to grow from $2.96 billion in 2024 to $3.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.1%. This historical increase can be ascribed to a heightened interest in neuropsychiatric drug development, the escalating prevalence of stress, anxiety, and depression, greater support from government and regulatory bodies, the expanding geriatric population, and an increasing demand for non-pharmacological interventions.

The mental health clinical trials market size is anticipated to undergo substantial growth in the upcoming years. It is projected to expand to $4.51 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is attributed to the increasing prevalence of mental health disorders, heightened awareness surrounding mental well-being, the growing need for personalized medicine, rising healthcare expenditure, and the expanding utilization of digital health technologies. Dominant trends for this timeframe include advancements in digital health platforms, technological progress in wearable devices, innovations in neuroimaging technologies, developments in electronic data capture (EDC) systems, and technology-enabled decentralized clinical trial models.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27343&type=smp

What Drivers Are Accelerating Expansion Of The Mental Health Clinical Trials Market?

An increasing incidence of mental health conditions is anticipated to drive the expansion of the mental health clinical trials market in the future. These disorders are defined as states that markedly impact an individual’s emotional state, thought processes, conduct, and general psychological well-being. The surge in mental health disorders stems from heightened stress associated with contemporary lifestyles, encompassing factors such as occupational demands, social detachment, and continuous digital engagement. Clinical trials in mental health are crucial for advancing patient care, as they assess the safety and efficacy of novel medications, treatments, and behavioral strategies tailored for mental health conditions. For example, reports from the American Psychiatric Association, a US-based non-profit organization, indicated in May 2024 that approximately 43% of adults in the USA experienced increased anxiety in 2024. This figure represents a rise from 37% in 2023 and 32% in 2022. Consequently, the growing occurrence of mental health disorders is fueling the expansion of the mental health clinical trials market.

What Are The Key Segment Trends Observed In The Mental Health Clinical Trials Market?

The mental health clinical trials market covered in this report is segmented

1) By Phase: Phase I, Phase II, Phase III, Phase IV

2) By Study Design: Interventional, Observational, Other Study Designs

3) By Disorder: Anxiety Disorders, Depression, Bipolar Affective Disorder, Dissociation And Dissociative Disorders, Schizophrenia, Other Disorders

4) By Sponsor: Pharmaceutical And Biopharmaceutical Companies, Government Agencies, Other Sponsors

Subsegments:

1) By Phase I: Single Ascending Dose, Multiple Ascending Dose, First In Human, Pharmacokinetics Studies

2) By Phase II: Dose Ranging Studies, Proof Of Concept Studies, Randomized Controlled Trials, Open Label Studies

3) By Phase III: Large Scale Randomized Trials, Multicenter Studies, Comparative Effectiveness Trials, Double Blind Studies

4) By Phase IV: Post Marketing Surveillance, Long Term Safety Studies, Real World Evidence Studies, Pharmacovigilance Studies

Which Disruptive Trends Are Driving Change Across The Mental Health Clinical Trials Market?

Major companies operating in the mental health clinical trials market are focusing on developing advanced treatments, such as adjunctive therapies, to improve efficacy, enhance patient outcomes, and address unmet needs in mental health disorders. Adjunctive therapies refer to medications used in combination with primary treatments to enhance their effectiveness in managing complex conditions. For instance, in December 2022, AbbVie Inc., a US-based biopharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for VRAYLAR (cariprazine) as an adjunctive treatment for major depressive disorder in adults. VRAYLAR offers a novel dopamine-serotonin partial agonist mechanism that complements traditional antidepressants. It helps reduce depressive symptoms in patients with inadequate response to standard therapy. The product also improves mood stabilization while reducing side effects commonly seen with older antipsychotics.

Who Are The Major Stakeholders Operating In The Mental Health Clinical Trials Market?

Major companies operating in the mental health clinical trials market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials, Inc., Ergomed, Celerion Inc., Biotrial S.A.S., Lindus Health Ltd., Novotech Health Holdings Pte Ltd., Precision for Medicine Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/mental-health-clinical-trials-global-market-report

What Regional Factors Are Accelerating Growth In The Mental Health Clinical Trials Market?

North America was the largest region in the mental health clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mental health clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27343&type=smp

Browse Through More Reports Similar to the Global Mental Health Clinical Trials Market 2025, By The Business Research Company

Aircraft Elevator Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aircraft-elevator-global-market-report

Smart Elevators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-elevators-global-market-report

Iot In Elevators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-elevators-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model